Bruker Corp EVP Munch exercises options, sells 7,000 shares (BRKR)

Rhea-AI Filing Summary

Bruker Corporation executive Mark Munch, EVP & President of Bruker Nano Inc., reported an option exercise and share sale in a Form 4. On January 12, 2026, he exercised a stock option for 7,000 shares of common stock at $22.19 per share, then sold 7,000 common shares at $55 per share on the same day. After these transactions, he directly owned 128,443 shares of Bruker common stock and held 18,000 stock options. The filing notes that the sales were made under a Rule 10b5-1 trading plan previously adopted by Munch.

Insider Trade Summary

Exercise and Sale: 7,000 shares ($230K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Munch Mark

Role EXEC VP&PRES BRUKER NANO INC.

Sold 7,000 shs ($385K)

Approx. gross sale proceeds $385K

Approx. exercise cost $155K

Approx. pre-tax spread $230K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Purchase)	7,000	$0.00	$0.00
Exercise	Common Stock	7,000	$22.19	$155K
Sale	Common Stock	7,000	$55.00	$385K

Holdings After Transaction: Stock Option (Right to Purchase) — 18,000 shares (Direct); Common Stock — 128,443 shares (Direct)

Footnotes (2)

1. F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
2. F2. The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vests on the first, second, third and fourth anniversaries of the Original Grant Date.

FAQ

What insider transaction did BRUKER (BRKR) report in this Form 4?

The Form 4 reports that executive Mark Munch exercised 7,000 stock options for Bruker common stock and sold 7,000 common shares on January 12, 2026.

Who is the insider involved in this Bruker (BRKR) Form 4 filing?

The reporting person is Mark Munch, who serves as Executive Vice President & President, Bruker Nano Inc. at Bruker Corporation.

How many Bruker (BRKR) shares did Mark Munch sell and at what price?

Mark Munch sold 7,000 shares of Bruker common stock at a price of $55 per share on January 12, 2026.

What stock option activity did Mark Munch report for Bruker (BRKR)?

He exercised a stock option for 7,000 shares of Bruker common stock at an exercise price of $22.19 per share, related to an option grant dated October 4, 2016.

How many Bruker (BRKR) shares and options does Mark Munch hold after the transactions?

Following the reported transactions, Mark Munch directly owned 128,443 shares of Bruker common stock and held 18,000 stock options.

Were the Bruker (BRKR) share sales made under a Rule 10b5-1 plan?

Yes. A footnote states that the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 01/13/2026 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Munch Mark

(Last) (First) (Middle)

BRUKER CORPORATION

40 MANNING ROAD

(Street)

BILLERICA MA 01821

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BRUKER CORP [ BRKR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EXEC VP&PRES BRUKER NANO INC.

3. Date of Earliest Transaction (Month/Day/Year)
01/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/12/2026		M		7,000	A	$22.19	135,443	D
Common Stock	01/12/2026		S		7,000(1)	D	$55	128,443	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Purchase)	$22.19	01/12/2026		M			7,000	(2)	10/04/2026	Common Stock	7,000	$0	18,000	D

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

2. The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vests on the first, second, third and fourth anniversaries of the Original Grant Date.

	/s/ Michael Simone, Attorney-in-Fact	01/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.